Reversible dimerization of 20 kilodalton human growth hormone (hGH)

Citation
Y. Nagatomi et al., Reversible dimerization of 20 kilodalton human growth hormone (hGH), GROWTH H I, 10(4), 2000, pp. 207-214
Citations number
20
Categorie Soggetti
Endocrinology, Nutrition & Metabolism
Journal title
GROWTH HORMONE & IGF RESEARCH
ISSN journal
10966374 → ACNP
Volume
10
Issue
4
Year of publication
2000
Pages
207 - 214
Database
ISI
SICI code
1096-6374(200008)10:4<207:RDO2KH>2.0.ZU;2-4
Abstract
A noncovalent dimer of the 22 kilodalton human growth hormone (22 K-hGH) is known to have diminished somatogenic activity compared with monomeric 22 K -hGH. In the present study, we examined the biological activity and physico chemical behaviour of a noncovalent dimer of the 20 kilodalton human growth hormone (20 K-hGH), an isoform of 22 K-hGH. Analysis of the equilibrium be tween monomeric and associated forms revealed that the associated 20 K-hGH was present in the dimeric form in aqueous solution. The kinetics of dimeri zation in rat plasma followed the theory of dissociation-association equili brium, and more than 99% of 20 K-hGH molecules existed as a monomer in the equilibrium state at the physiological hGH concentration. Analysis of the p harmacokinetics showed that the ratio of the administrated dimer in rat cir culation decreased from 43% to less than 4% in 2 h. A preparation of noncov alent dimeric 20 K-hGH had essentially the same degree of biological potenc y as that of a monomer in both in vitro and in vivo bioassays. In conclusio n, dimerization of 20 K-hGH is reversible both in vitro and in vivo and a n oncovalent dimer can function as a pharmaceutically active component of a 2 0 K-hGH preparation, in contrast to a 22 K-hGH preparation. (C) 2000 Harcou rt Publishers Ltd.